FDA Issues Guidance On Expansion Cohorts In Clinical Trials Of Oncology Drugs

The FDA issued the final guidance document for first-in-human trial designs that consist of both dose escalation as well as multiple expansion...

Related Keywords

United States ,Marjoriee Zettler ,Le Tourneau ,Drug Administration ,Regor Pharmaceuticals Inc ,Research To Accelerate Cures ,Regor Pharmaceuticals ,Accelerate Cures ,Children Act ,States Food ,Expansion Cohorts ,First In Human Clinical Trials ,Expedite Development ,Oncology Drugs ,Study Evaluating ,Subjects With Solid Tumors ,Adults With Non Small Cell Lung ,Human Bispecific ,Met Antibody ,Patients With Thyroid Cancer ,Non Small Cell Lung Cancer ,Participants With Advanced Solid Tumors ,Positive Solid Tumors ,Medullary Thyroid Cancer ,Older Adults ,Cancer Clinical ,Cancer Clinical Trial Eligibility Criteria ,Organ Dysfunction ,Minimum Age Considerations ,Adolescent Patients ,Adult Oncology Clinical ,Rev Anticancer ,